Loading…
Agenus Inc. is projected to rise to $8.01 by 2027, a +7% move from its current price of $7.50. AGEN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $7.03 | $7.50 | $8.00 | -0.01% |
| Aug 4 | $6.84 | $7.50 | $8.22 | -0.03% |
| Aug 5 | $6.70 | $7.50 | $8.39 | -0.04% |
| Aug 6 | $6.58 | $7.50 | $8.54 | -0.06% |
| Aug 7 | $6.48 | $7.49 | $8.67 | -0.07% |
| Aug 8 | $6.39 | $7.49 | $8.79 | -0.08% |
| Aug 9 | $6.31 | $7.49 | $8.90 | -0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.31 | $7.49 | $8.90 | -0.10% |
| Week 2 | $5.87 | $7.49 | $9.55 | -0.20% |
| Week 3 | $5.55 | $7.48 | $10.07 | -0.30% |
| Week 4 | $5.30 | $7.47 | $10.54 | -0.40% |
| Week 5 | $5.08 | $7.46 | $10.96 | -0.49% |
| Week 6 | $4.89 | $7.46 | $11.36 | -0.59% |
| Week 7 | $4.73 | $7.45 | $11.74 | -0.69% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Agenus Inc. is a clinical-stage biotechnology company that discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for identifying fully human and humanized monoclonal antibodies, and display technologies.
It also develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant.
The company maintains a diverse pipeline that includes Balstilimab, AGEN1181, AGEN2373, AGEN1423, AGEN1571, BMS-986442, INCAGN1876, INCAGN2390, INCAGN2385, MK-4830, and AGEN1884, among others. Agenus operates under the trademarks Agenus, MiNK, Prophage, Retrocyte Display, and STIMULON, and has collaborations with Bristol-Myers Squibb, Betta Pharmaceuticals Co., Ltd., UroGen Pharma Ltd., Gilead Sciences, Inc., Incyte Corporation, and Merck Sharp & Dohme.
The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus was founded in 1994 and is headquartered in Lexington, Massachusetts.
Agenus Inc. (AGEN) is a healthcare stock with a current price of $7.91 and a market cap of $329.39M. It ranks 3197 by market capitalization, reflecting its position in the healthcare landscape.
Trading activity sits within a technical frame that shows bullish sentiment, supported by a bullish reading on the RSI and notable moving averages. The stock has a defined support at $2.88 and a resistance at $7.91, with a 30-day price range of $5.12 to $12.23.
Forecasts point to a multi-year upside with rising averages and ROIs, highlighted by strong 2030, 2040, and 2050 projections. These imply meaningful longer-term appreciation despite near-term variability.
A major floor 85.8% below — a decisive break under it would weaken the trend.
The nearest floor, 61.6% below — buyers have tended to step in here.
The nearest ceiling, 5.5% above — a clean break opens room to run.
A major ceiling 48.4% above — clearing it would confirm fresh momentum.
Key AGEN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AGEN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.95 | Buy | $7.05 | Buy |
| MA 10 | $6.30 | Buy | $6.44 | Buy |
| MA 20 | $5.30 | Buy | $5.61 | Buy |
| MA 50 | $4.04 | Buy | $4.58 | Buy |
| MA 100 | $3.91 | Buy | $4.12 | Buy |
| MA 200 | $3.78 | Buy | $4.02 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 74.30 | Sell |
| Stoch RSI (14) | 60.27 | Neutral |
| CCI (20) | 131.28 | Buy |
| Williams %R (14) | -13.95 | Info |
| MACD (12,26,9) | 0.23 | Buy |
| ROC (12) | 49.70 | Buy |
| Bollinger %B (20,2) | 0.90 | Neutral |
| Stochastic %K (14) | 86.05 | Sell |
| TRIX (15) | 2.68 | Buy |
| Awesome (5,34) | 2.56 | Buy |
| Ultimate (7,14,28) | 74.85 | Sell |
| Momentum (10) | 2.49 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 7.62 | Sell |
| ADX (14) | 33.01 | Buy |
| ATR (14) | 0.36 | Info |
The 30-day technical picture is bullish, with RSI14 at 80 and momentum indicated by the moving averages: SMA50 at $3.95 and SMA200 at $3.76.
The price trades around a resistance level of $7.91 and sits above a support at $2.88. The 30-day price range is $5.12 to $12.23, underscoring near-term volatility within a bullish context.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.77 | $7.50 | $10.87 | 0% | Neutral | |
| $5.83 | $8.01 | $11.88 | +7% | Neutral | |
| $6.46 | $9.44 | $14.94 | +26% | Bullish | |
| $7.49 | $11.53 | $19.17 | +54% | Bullish | |
| $10.24 | $16.52 | $28.61 | +120% | Bullish | |
| $10.92 | $18.42 | $33.03 | +146% | Bullish | |
| $9.84 | $17.32 | $32.02 | +131% | Bullish | |
| $10.09 | $18.49 | $35.14 | +147% | Bullish | |
| $9.79 | $18.66 | $36.38 | +149% | Bullish | |
| $9.92 | $19.65 | $39.19 | +162% | Bullish | |
| $14.29 | $31.76 | $69.66 | +323% | Bullish | |
| $32.49 | $72.21 | $166.09 | +863% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.77 | $7.50 | $9.41 | +0.00% |
| September 2026 | $5.95 | $7.24 | $9.20 | -3.46% |
| October 2026 | $6.00 | $7.40 | $9.59 | +2.26% |
| November 2026 | $6.49 | $8.09 | $10.65 | +9.30% |
| December 2026 | $6.46 | $8.14 | $10.87 | +0.62% |
Click any year to see its month-by-month AGEN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AGEN to range from $2.77 to $10.87 through 2026. The $7.50 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The AGEN price prediction for 2027 points to an average of $8.01 (low $5.83, high $11.88) — a potential gain of +7% on today's $7.50. A consolidation phase looks the most probable path here.
In 2028, AGEN is projected to trade between $6.46 and $14.94, averaging $9.44 — a potential gain of +26% from today's $7.50. That is up +18% on the projected 2027 average. Momentum favours further upside here.
Agenus Inc.'s 2029 outlook centres on $11.53, within a $7.49 to $19.17 range. That is up +22% on the projected 2028 average. That marks a +54% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, AGEN could reach as high as $28.61, with a base case around $16.52 and support toward $10.24 — roughly +120% from $7.50. Momentum favours further upside here.
Expect AGEN to range from $10.92 to $33.03 through 2031. The $18.42 average target implies a +146% move from current prices. That is up +11% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The AGEN price prediction for 2032 points to an average of $17.32 (low $9.84, high $32.02) — a potential gain of +131% on today's $7.50. Momentum favours further upside here.
In 2033, AGEN is projected to trade between $10.09 and $35.14, averaging $18.49 — a potential gain of +147% from today's $7.50. That is up +7% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Agenus Inc.'s 2034 outlook centres on $18.66, within a $9.79 to $36.38 range. That is up +1% on the projected 2033 average. That marks a +149% change versus current levels. Momentum favours further upside here.
By 2035, AGEN could reach as high as $39.19, with a base case around $19.65 and support toward $9.92 — roughly +162% from $7.50. Buyers look set to stay in control over this stretch.
Expect AGEN to range from $14.29 to $69.66 through 2040. The $31.76 average target implies a +323% move from current prices. That is up +62% on the projected 2035 average. Momentum favours further upside here.
The AGEN price prediction for 2050 points to an average of $72.21 (low $32.49, high $166.09) — a potential gain of +863% on today's $7.50. Buyers look set to stay in control over this stretch.
Investing $1,000 in AGEN today (≈ 133.333333 AGEN) could be worth
$9,628.14
+$8,628.14 (+863%) by 2050 · US Dollar
Based on the average projected AGEN price of $72.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AGENwould be worth at today's price.
$1,000 invested in AGEN on Jul 31, 2025 (≈ 181.159421 AGEN) would be worth
$1,358.7
+$358.7 (+35.9%) today · 1.36× · US Dollar
Based on a AGEN entry price of $5.52 vs. today's $7.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.98 | $1,254.18 | +25.4% |
| 1 month ago | $3.41 | $2,199.41 | +119.9% |
| 3 months ago | $3.84 | $1,953.13 | +95.3% |
| 6 months ago | $2.86 | $2,622.38 | +162.2% |
| 1 year ago | $5.52 | $1,358.7 | +35.9% |
| All time (5.0y) ago | $106.97 | $70.11 | -93.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AGEN forecast.
Our base-case forecast reaches $15.00 around 2030.
Implied market cap at $15.00: $624.64M
2026 forecasts show a near-term baseline with min $2.77, avg $7.91, max $11.47 and ROI 0, indicating a neutral stance in the very near term.
By 2030, the forecast envisions an average price of $17.93 with a min of $11.11 and a max of $31.06, yielding an ROI of 126.7 and a bullish sentiment. That trajectory continues into 2040, where the average is projected at $34.96 with a max of $76.68 and an ROI of 341.9.
For 2050, the forecast shows an average of $80.95 and a max of $186.18, with an ROI of 923.4 and bullish sentiment. These figures illustrate substantial long-term upside potential alongside the near-term uncertainty reflected in the 2026 leg.
Tap a question to reveal the answer.
The forecast shows an average price of $17.93, a range from $11.11 to $31.06, with an ROI of 126.7 and a bullish sentiment.
Current price $7.91; market cap $329.39M.
Yes—the 2050 max is $186.18, which is above $100.
RSI14 80; SMA50 at $3.95; SMA200 at $3.76; support $2.88; resistance $7.91; 30-day range $5.12-$12.23; sentiment bullish.
Min $2.77, avg $7.91, max $11.47; ROI 0; sentiment Neutral.
Agenus Inc. Community Discussion
0Share your Agenus Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.